Drawing for CRYSTALPHARM

USPTO serial 76302323

CRYSTALPHARM

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
JOHNSON, AISHA CLARKE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CRYSTALPHARM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jason K. Schmitz

JASON K SCHMITZ MAYER, BROWN & PLATTP O BOX 2828CHICAGO, IL 60690-2828UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Chemicals used in industry and science, namely bioactive compounds for use in clinical diagnostics; a full line of medicines for the treatment of human diseasesACTIVEOct 30, 1999
042Research, namely chemical component development in the field of life science, in particular the pharmaceutical and agricultural chemistry industry; research and development of medicines, medicinal preparation and diagnostic preparations; research and development in the field of diagnostic preparations and pharmaceuticals; performing commissioned research in the field of medical diagnostics and pharmaceutical research; database development and computer programming; database mangement services, namely, collecting, preparing, archiving, updating, evaluating and reporting on data for third parties; chemical analysis allACTIVEOct 30, 1999

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 21, 2003ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 20, 2002CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 15, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 15, 2002MAILPAPER RECEIVED—
Oct 2, 2002CNSLLETTER OF SUSPENSION MAILED—
Sep 5, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 5, 2002MAILPAPER RECEIVED—
May 14, 2002CNSLLETTER OF SUSPENSION MAILED—
Feb 11, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 25, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 24, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance